Newsfeeds Archive - Spark Newswire

3 minute read

Lisata Therapeutics Announces Completion Of Enrollment In Phase 2b ASCEND Trial Of LSTA1 In Metastatic Pancreatic Ductal Adenocarcinoma

December 12, 9:05 AM

Enrollment completed approximately six months earlier than originally projected Top-line placebo-controlled, blinded, randomized data now expected in the fourth quarter of 2024BASKING RIDGE, N.J., Dec. 12, 2023

LSTA

29 minute read

Earnings

Earnings Scheduled For November 2, 2023

By Benzinga Insights

November 2, 4:56 AM

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

AAPL

1 minute read

Earnings

Earnings Preview: Lisata Therapeutics

By Benzinga Insights

November 1, 3:01 PM

Lisata Therapeutics (NASDAQ:LSTA) is set to give its latest quarterly earnings report on Thursday, 2023-11-02. Here’s what investors…

LSTA

2 minute read

Lisata Therapeutics Announces First Patient Treated In The Cholangiocarcinoma Cohort Of The BOLSTER Trial Of LSTA1, A Novel Tumor-Targeting And Penetrating Peptide

By Benzinga Newsdesk

October 24, 8:17 AM

Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today

LSTA

10 minute read

Options

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

September 5, 1:34 PM

On Tuesday, 164 companies achieved new lows for the year.

ABLV

12 minute read

Earnings

Earnings Scheduled For August 14, 2023

By Benzinga Insights

August 14, 6:45 AM

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

AAMC

29 minute read

Earnings

Earnings Scheduled For May 9, 2023

By Benzinga Insights

May 9, 6:03 AM

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.

ABNB

1 minute read

Lisata Therapeutics Receives $2.2M Of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

By Benzinga Newsdesk

April 20, 8:49 AM

LSTA

6 minute read

Earnings

Earnings Scheduled For March 30, 2023

By Benzinga Insights

March 30, 7:24 AM

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.

AACG

9 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

December 23, 1:16 PM

OnFriday, 143 stocks hit new 52-week lows.

ACHR